# NuCana plc: financial statements, quarterly

NCNA · Nasdaq · CIK 1709626 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ncna.md) · [Financials](/companies/ncna/financials.md) · [Filings](/companies/ncna/filings.md) · [Insiders](/companies/ncna/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ncna/financials.md?period=annual).

## Balance sheet

| Line item | Unit | period not labelled (2014-12-31) | period not labelled (2015-12-31) | period not labelled (2016-12-31) | FY2017 (2017-12-31) | FY2018 (2018-12-31) | FY2019 (2019-12-31) | FY2020 (2020-12-31) | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [18.8](/filings/0001564590-18-006509.md) | [14.1](/filings/0001564590-19-006811.md) | [20.0](/filings/0001564590-20-009788.md) | [86.7](/filings/0001564590-21-010959.md) | [77.0](/filings/0001564590-22-016088.md) | [52.0](/filings/0000950170-23-011778.md) | [87.4](/filings/0000950170-24-034208.md) | [60.3](/filings/0000950170-25-042709.md) | [41.9](/filings/0001193125-26-116030.md) | [17.2](/filings/0001193125-26-116030.md) | [6.7](/filings/0001193125-26-116030.md) | [24.3](/filings/0001193125-26-116030.md) |
| Current assets | $m | not reported | not reported | [25.8](/filings/0001564590-18-006509.md) | [94.0](/filings/0001564590-19-006811.md) | [83.6](/filings/0001564590-20-009788.md) | [65.2](/filings/0001564590-21-010959.md) | [102](/filings/0001564590-22-016088.md) | [71.6](/filings/0000950170-23-011778.md) | [54.9](/filings/0000950170-24-034208.md) | [25.0](/filings/0000950170-25-042709.md) | [12.3](/filings/0001193125-26-116030.md) | [26.9](/filings/0001193125-26-116030.md) |
| Total assets | $m | not reported | not reported | [27.2](/filings/0001564590-18-006509.md) | [96.4](/filings/0001564590-19-006811.md) | [87.2](/filings/0001564590-20-009788.md) | [70.3](/filings/0001564590-21-010959.md) | [108](/filings/0001564590-22-016088.md) | [77.5](/filings/0000950170-23-011778.md) | [58.3](/filings/0000950170-24-034208.md) | [27.8](/filings/0000950170-25-042709.md) | [14.8](/filings/0001193125-26-116030.md) | [29.8](/filings/0001193125-26-116030.md) |
| Current liabilities | $m | not reported | not reported | [2.0](/filings/0001564590-18-006509.md) | [2.9](/filings/0001564590-19-006811.md) | [5.6](/filings/0001564590-20-009788.md) | [6.2](/filings/0001564590-21-010959.md) | [8.1](/filings/0001564590-22-016088.md) | [11.7](/filings/0000950170-23-011778.md) | [19.3](/filings/0000950170-24-034208.md) | [12.7](/filings/0000950170-25-042709.md) | [8.7](/filings/0001193125-26-116030.md) | [4.8](/filings/0001193125-26-116030.md) |
| Total liabilities | $m | not reported | not reported | [2.0](/filings/0001564590-18-006509.md) | [2.9](/filings/0001564590-19-006811.md) | [5.6](/filings/0001564590-20-009788.md) | [6.7](/filings/0001564590-21-010959.md) | [8.6](/filings/0001564590-22-016088.md) | [11.9](/filings/0000950170-23-011778.md) | [19.8](/filings/0000950170-24-034208.md) | [12.9](/filings/0000950170-25-042709.md) | [8.8](/filings/0001193125-26-116030.md) | [5.5](/filings/0001193125-26-116030.md) |
| Shareholders' equity | $m | [34.5](/filings/0001564590-18-006509.md) | [30.0](/filings/0001564590-19-006811.md) | [25.2](/filings/0001564590-18-006509.md) | [93.4](/filings/0001564590-18-006509.md) | [81.6](/filings/0001564590-22-016088.md) | [63.5](/filings/0000950170-23-011778.md) | [99.2](/filings/0000950170-24-034208.md) | [65.5](/filings/0000950170-25-042709.md) | [38.5](/filings/0001193125-26-116030.md) | [14.9](/filings/0001193125-26-116030.md) | [6.0](/filings/0001193125-26-116030.md) | [24.3](/filings/0001193125-26-116030.md) |

- Cash and equivalents: ifrs-full:CashAndCashEquivalents
- Current assets: ifrs-full:CurrentAssets
- Total assets: ifrs-full:Assets
- Current liabilities: ifrs-full:CurrentLiabilities
- Total liabilities: ifrs-full:Liabilities
- Shareholders' equity: ifrs-full:Equity, ifrs-full:EquityAttributableToOwnersOfParent

Shares outstanding: 20,809,854,947 at 2025-12-31, from the cover of the [20-F filed 2026-03-19](/filings/0001193125-26-116030.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:46 ET. No prices; not investment advice.